Provided by Tiger Trade Technology Pte. Ltd.

Merus NV

90.00
0.0000
Volume:- -
Turnover:252.73M
Market Cap:6.83B
PE:-16.79
High:90.00
Open:90.00
Low:90.00
Close:90.00
52wk High:97.14
52wk Low:33.19
Shares:75.85M
Float Shares:65.61M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3613
EPS(LYR):-3.3529
ROE:-51.57%
ROA:-26.53%
PB:8.81
PE(LYR):-26.84

Loading ...

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Merus (MRUS)

TIPRANKS
·
Nov 04, 2025

Truist Financial Reaffirms Their Hold Rating on Merus (MRUS)

TIPRANKS
·
Nov 04, 2025

Merus NV’s Financial Stability at Risk Due to Unproven ADClonics Technology and Supply Chain Vulnerabilities

TIPRANKS
·
Nov 02, 2025

Merus NV reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 01, 2025

Merus NV Announces Date for Extraordinary General Meeting of Shareholders

Reuters
·
Nov 01, 2025

Assessing Merus (MRUS) Valuation After This Year’s 120% Share Price Rally

Simply Wall St.
·
Oct 31, 2025

Merus to present interim data on petosemtamab at AACR-NCI-EORTC conference

TIPRANKS
·
Oct 24, 2025

Merus Reports 100% Response Rate in First-Line Metastatic Colorectal Cancer Trial

Reuters
·
Oct 24, 2025

Genmab Launches $97-Per-Share Tender Offer for Merus

Reuters
·
Oct 21, 2025

Merus (MRUS): Reviewing Valuation Following Strong Share Price Gains

Simply Wall St.
·
Oct 21, 2025

BUZZ-Corbus Pharma jumps after early data for cancer therapy

Reuters
·
Oct 20, 2025

Oppenheimer positive on CytomX after Merus colon cancer data

TIPRANKS
·
Oct 15, 2025

Merus NV to Present Promising Phase 2 Data for Petosemtamab in Metastatic Colorectal Cancer at Major Oncology Conference

Reuters
·
Oct 14, 2025

Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Exelixis (EXEL) and Sanofi (OtherSNYNF)

TIPRANKS
·
Oct 09, 2025

Merus Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
Oct 06, 2025

Merus Nv : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $97 From $95

THOMSON REUTERS
·
Oct 06, 2025

Merus downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
Oct 06, 2025

Genmab to Acquire Merus NV in $8 Billion Deal

Reuters
·
Oct 04, 2025

Unusually active option classes on open October 2nd

TIPRANKS
·
Oct 02, 2025

HBM Healthcare Investments Reports CHF 236 Million Quarterly Profit, NAV Up 16.4%

Reuters
·
Oct 01, 2025